Literature DB >> 8097545

Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex.

H A Lehr1, M Kröber, C Hübner, P Vajkoczy, M D Menger, D Nolte, A Kohlschütter, K Messmer.   

Abstract

BACKGROUND: The adhesion of leukocytes to the vascular endothelium has been identified as a constant, early feature of atherogenesis. Using a skinfold chamber model in hamsters for intravital microscopy, we have recently demonstrated the chemotactic and adhesion-promoting action of oxidatively modified low density lipoprotein (oxLDL) in vivo. EXPERIMENTAL
DESIGN: In order to rule out a species specificity of the experimental approach, and to investigate the involvement of leukocyte adhesion receptors in oxLDL-induced leukocyte/endothelium interaction, we have adapted the skinfold chamber model to hairless mice. Using intravital fluorescence microscopy, leukocyte/endothelium interaction in a fine striated skin muscle was assessed during the time course after intravenous injection of native human LDL (4 mg/kg body weight) and oxLDL (oxidized in vitro by 7.5 microM Cu2+, 6 hours, 37 degrees C) into control mice and into mice pretreated with either the selective inhibitor of leukotriene biosynthesis MK-886 (20 mumol/kg body weight, intravenously, 10 minutes before oxLDL) or with a monoclonal antibody directed towards the CD11b subunit of the CD11b/CD18 adhesion receptor complex on leukocytes (monoclonal antibody anti-Mac1, 0.5 mg/kg, iv, 10 minutes before oxLDL).
RESULTS: We demonstrate in this study that injection of oxLDL (4 mg LDL-cholesterol/kg, intravenously, oxidized by 7.5 microM Cu2+, 6 hours, 37 degrees C), but not of native LDL or LDL-free Cu(2+)-solution, elicits the adhesion of fluorescently stained leukocytes to the endothelium of postcapillary venules (173 +/- 75 cells/mm2 at 20 minutes after oxLDL, mean +/- SD) and arterioles (119 +/- 74 cells/mm2 at 20 minutes after oxLDL, mean +/- SD) in the mice. OxLDL-induced leukocyte adhesion was entirely prevented by pretreatment of the animals with the inhibitor of leukotriene biosynthesis or with monoclonal antibody anti-Mac-1.
CONCLUSIONS: These results demonstrate the involvement of leukotrienes and of the CD11b/CD18 adhesion receptor complex in oxLDL-induced leukocyte adhesion in vivo and rule out a species specificity of this pathophysiologic event.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097545

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

Review 1.  Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Dorsal skinfold chamber technique for intravital microscopy in nude mice.

Authors:  H A Lehr; M Leunig; M D Menger; D Nolte; K Messmer
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

3.  In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.

Authors:  H A Lehr; F Krombach; S Münzing; R Bodlaj; S I Glaubitt; D Seiffge; C Hübner; U H von Andrian; K Messmer
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

Review 4.  Mechanism of action of niacin on lipoprotein metabolism.

Authors:  V S Kamanna; M L Kashyap
Journal:  Curr Atheroscler Rep       Date:  2000-01       Impact factor: 5.967

Review 5.  Dark nights behind the white clouds - risks of tobacco smoking on human health besides the oral health and malignancy.

Authors:  Zarin Zainul
Journal:  EXCLI J       Date:  2011-05-12       Impact factor: 4.068

6.  A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses.

Authors:  Filip K Swirski; Cedric R Berger; Jose-Luiz Figueiredo; Thorsten R Mempel; Ulrich H von Andrian; Mikael J Pittet; Ralph Weissleder
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.